Glucose monitor study for diabetes and peritoneal dialysis
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses a continuous glucose monitor to track blood sugar levels in people with diabetes who are on peritoneal dialysis. It may help improve diabetes management during dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have type 1 or type 2 diabetes for at least 3 months.
- You are on peritoneal dialysis for at least 3 months, or you plan to start it within the next 3 months.
- You are willing to wear a glucose sensor and follow the study schedule.
- You are not planning to switch to hemodialysis or get a kidney transplant within the next 3 months.
- You do not have severe skin problems at the sensor sites and are not allergic to medical adhesives.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
This study tests if using a continuous glucose monitor (a sensor that checks your sugar levels all day) can improve blood sugar control in people with type 2 diabetes and kidney disease. You may join if your kidneys are at stage 3 or 4 (not on dialysis or transplant) and you take insulin.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
Hear when a new Continuous Glucose Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.